跳至主要内容
临床试验/NCT07094802
NCT07094802尚未招募4 期

Comparison of Intrathecal Bupivacaine With and Without Morphine for Post-operative Analgesia in Parturients Undergoing Elective Cesarean Section: A Randomized Controlled Trial

Tribhuvan University Teaching Hospital, Institute Of Medicine.0 个研究点目标入组 92 人开始时间: 2025年10月15日最近更新:
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
92
主要终点
NRS score

研究概览

简要总结

The goal of this clinical trial is to compare intrathecal bupivacaine with or without morphine for postoperative analgesia in patients undergoing elective cesarean section. The main questions it aims to answer are:

Is intrathecal bupivacaine with morphine superior to intrathecal bupivacaine alone for postoperative analgesia for parturients undergoing cesarean section? What is the duration of analgesia in the two groups? Researchers will compare drug intrathecal bupivacaine with morphine to a iintrathecal bupivacaine alone to see if intrathecal morphine has benefits for psotoperative analgesia .

Participants will:

Get intrathecal bupivacaine with Morphine or intrathecal bupivacaine alone during spinal anesthesia for cesarean section.

They will be followed up for NRS pain scores and side effects for 24 hours. Time to need of first rescue analgesic will be noted

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Parturients undergoing elective caesarean section under Spinal anesthesia
  • ASA PS II, III
  • > 18 years

排除标准

  • Refusal to Participate
  • Contraindications to spinal anaesthesia and adjuvants INR ≥ 1.5 Plateletes < 1,00,000/cumm Severe aortic stenosis, and/or severe mitral stenosis Infection at lumbar puncture site Known allergy to local anesthetics and opioids
  • Communication barrier
  • Height <150 cm

研究组 & 干预措施

Morphine Group

Active Comparator

This group will receive 2.2 ml of 0.5% hyperbaric bupivacaine + 100 mcg (0.1 ml of 1 mg/ml) Morphine intrathecally during spinal anesthesia

干预措施: Intrathecal morphine with bupivacaine (Drug)

Bupivacaine Group

Placebo Comparator

This group will receive 2.2 ml of 0.5% hyperbaric bupivacaine during spinal anesthesia

干预措施: Hyperbaric Bupivicaine (Drug)

结局指标

主要结局

NRS score

时间窗: 24 hours

comapre NRS score at 0,1,6,12,18,24 hours between the groups

Time to need of first rescue analgesic

时间窗: within 24 hours

time of spinal anesthesia to time of demand of first rescue analgesic

次要结局

  • 24 hours analgesic consumption(24 hours)

研究者

发起方
Tribhuvan University Teaching Hospital, Institute Of Medicine.
申办方类型
Other
责任方
Principal Investigator
主要研究者

Megha Patrabansha

Dr., Resident

Tribhuvan University Teaching Hospital, Institute Of Medicine.

相似试验